LSD (lysergic acid diethylamide)

URI: https://gptkb.org/entity/LSD_(lysergic_acid_diethylamide)

GPTKB entity

Statements (66)

Predicate	Object
gptkbp:instanceOf	Hallucinogen
gptkbp:abusePotential	not considered addictive
gptkbp:allows	rapidly develops
gptkbp:aroma	odorless
gptkbp:CASNumber	50-37-3
gptkbp:category	Hallucinogen ergoline tryptamine
gptkbp:chemicalFormula	C20H25N3O
gptkbp:color	colorless
gptkbp:discoveredBy	gptkb:Albert_Hofmann
gptkbp:discoveredIn	1938
gptkbp:duration_of_action	8–12 hours
gptkbp:effect	anxiety euphoria hallucinations synesthesia altered perception spiritual experiences
gptkbp:eliminationHalfLife	3–5 hours
gptkbp:enemyOf	gptkb:chlorpromazine gptkb:haloperidol
gptkbp:excretion	renal
gptkbp:firstSynthesized	gptkb:Sandoz_Laboratories
gptkbp:flavor	slightly bitter
https://www.w3.org/2000/01/rdf-schema#label	LSD (lysergic acid diethylamide)
gptkbp:IUPACName	(6aR,9R)-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
gptkbp:legalStatus	Class A drug (UK) Schedule I controlled substance (US)
gptkbp:meltingPoint	80–85 °C
gptkbp:metabolism	hepatic
gptkbp:molecularWeight	323.43 g/mol
gptkbp:notable_historical_use	counterculture of the 1960s MKUltra project
gptkbp:notableFigure	gptkb:Aldous_Huxley gptkb:Ken_Kesey gptkb:Timothy_Leary gptkb:Richard_Alpert
gptkbp:onset_of_action	30–60 minutes
gptkbp:origin	gptkb:ergot_fungus
gptkbp:overdose_risk	very low
gptkbp:PubChem_CID	5761
gptkbp:receptor_affinity	5-HT2A receptor agonist dopamine receptor agonist
gptkbp:relatedTo	gptkb:DMT psilocybin mescaline ergine
gptkbp:routeOfAdministration	oral intravenous sublingual
gptkbp:solubility	water-soluble
gptkbp:street_names	gptkb:carboxylic_acid blotter tabs lucy
gptkbp:toxicity	low acute toxicity
gptkbp:UNII	D839GV0YJ7
gptkbp:used_in	psychedelic therapy recreational drug use
gptkbp:visual_form	gptkb:water blotter paper gel tabs microdots
gptkbp:bfsParent	gptkb:Ergotism
gptkbp:bfsLayer	7